Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00103363 · ClinicalTrials.gov registry record · Phase 2
Sputum Cytology in Screening Heavy Smokers For Lung Cancer
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 3,270
- Enrollment target
NCT00103363 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 3,270 participants.
The verdict
NCT00103363, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3,270 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early and plan better treatment for lung cancer. PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy smokers for lung cancer.
Interventions
- OTHER cytology specimen collection procedure
- OTHER physiologic testing
- PROCEDURE study of high risk factors
- PROCEDURE annual screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,270 participants |
| Start Date | 1993-02 |
| Est. Completion | 1994-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00103363
The ClinicalTrials.gov registry entry for NCT00103363 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3,270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which cytology specimen collection procedure is the first listed.
NCT00103363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00103363 about?
NCT00103363 is a clinical study titled "Sputum Cytology in Screening Heavy Smokers For Lung Cancer". RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early and plan better treatment for lung cancer. PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy smokers for lung cancer.
What is the current status of trial NCT00103363?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3,270 participants. The study started on 1993-02. Estimated completion is 1994-02.
What interventions are being tested in trial NCT00103363?
The interventions under investigation include: cytology specimen collection procedure (OTHER), physiologic testing (OTHER), study of high risk factors (PROCEDURE), annual screening (PROCEDURE).
Who is sponsoring clinical trial NCT00103363?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.